Intranasal COVID-19 vaccine: Bharat Biotech ties up with FluGen, UW-Madison virologists

Intranasal COVID-19 vaccine: Bharat Biotech ties up with FluGen, UW-Madison virologists CoroFlu could be in human clinical trials by fall (September-December) of 2020, Bharat Biotech statement said.

No comments:

Post a Comment